Group B Streptococcus Infection and PROM Incidince

Incidince of PROM with GBS Infection and Prophylaxis Against It

Status

Not yet recruiting

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT06735703

Enrollment

150

Registered

2024-12-16

Start date

2024-12-25

Completion date

2026-01-09

Last updated

2024-12-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Group B Streptococcal Infection, Premature Rupture of Fetal Membranes

Brief summary

To investigate incidince of prom with GBS infection and role of prophylaxis against it

Interventions

DRUGTo provide ampicillin sulbactam to pregnant women with premature rupture of membrane

To provide ampicillin sulbactam tonpregnant women with premature rupture of membrane after 34 wks gestation

Study design

Observational model

COHORT

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

FEMALE

Healthy volunteers

Inclusion criteria

* Pregnant women with prom after 34 wks festation

Exclusion criteria

* Bleeding disorder * emergency conditions

Design outcomes

Primary

Measure	Time frame
Incidince of prom with GBS infection and prophylaxis against it	Baseline

Contacts

Primary ContactDina Mohamed Kamel

dinakamel802@gmail.com0927923623

Backup ContactSherif Abdelmeged badran

0927923623

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026